Glioblastoma is a deadly brain cancer with poor outcomes. But the final results of a phase III trial reveal that a novel treatment could increase survival.
Learn more about treatments for mastectomy scars. We run through the options for women and provide details on types of mastectomy procedures.
Why are some breast cancers more aggressive than others? A new study sheds light on a key molecular interaction that makes cancer more treatment-resistant.
With hundreds waiting for heart transplants, experts and patients urge public to register as organ donors â€“ and make their wishes clear to family membersFamilies are being urged to talk about becoming an organ donor in the hope that more people on th…
ZURICH (Reuters) – The U.S. Food and Drug Administration has granted priority review for Novartis’s Tafinlar in combination with Mekinist for treating some patients with advanced melanoma, the Swiss drugmaker said on Friday.
(Reuters) – Swiss drugmaker Roche will buy U.S. cancer drug specialist Ignyta Inc for $1.7 billion in an agreed deal to broaden its oncology portfolio, the firms said on Friday.
An electronic “scoreboard” can now track any sudden changes in patients’ health at a Welsh hospital.
A charity wants to “normalise” testing and reduce the stigma of getting checked out.
(Reuters) – The paramedics find them everywhere – slumped over car steering wheels, barely breathing in doughnut shop bathrooms or dead in derelict apartments and expensive mansions.
By Dr. Mercola
While the thought of growing artichokes might be intimidating, I assure you that bringing a taste of the Mediterranean to your garden may be easier than you may have imagined. Artichokes are tasty when served fresh from the garden, and …
By Dr. Mercola
Moringa is an incredibly nutrient-rich plant touted as a superfood due to its many health benefits. Its small, rounded leaves are packed with significant amounts of nutrition: beta carotene, calcium, magnesium, potassium, protein and …
This article originally appeared on HuffPost.
(Reuters) – Ignyta Inc is in advanced talks to sell itself, people familiar with the matter said on Thursday, just three years after the U.S. cancer drugmaker became a public company focused on precision drugs and diagnostics.
A teenager is reaching out to young people struggling with depression over the festive period.
But Public Health England is urging more people in their 70s to get their free injection.
In clinical trials, Giapreza effectively increased blood pressure when added to conventional treatments used to raise blood pressure, the FDA said. FDA Approvals
An Oxford firm has developed a device to sequence the genome of malaria parasites to help doctors detect the strain they’re dealing with.
(Reuters) – California’s top court on Thursday opened the door for consumers to sue Novartis AG and other makers of brand-name pharmaceutical products over injuries blamed on generic versions of the drugs manufactured by other companies.
(Reuters) – La Jolla Pharmaceutical said on Thursday the U.S. Food and Drug Administration had approved its drug, Giapreza, to treat dangerously low blood pressure.
CHICAGO (Reuters) – The opioid crisis is rippling through the U.S. healthcare system, causing a spike in rates of hepatitis C related to increased opioid injections and reducing overall life expectancy among Americans, which has fallen for the second y…